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Neisseria meningitidis is a human pathogen that causes septicemia and meningitis with high mortality. The disease
progression is rapid and much remains unknown about the disease process. The understanding of disease development is
crucial for development of novel therapeutic strategies and vaccines against meningococcal disease. The use of
bioluminescent imaging combined with a mouse disease model allowed us to investigate the progression of meningococcal
sepsis over time. Injection of bacteria in blood demonstrated waves of bacterial clearance and growth, which selected for Opa-
expressing bacteria, indicating the importance of this bacterial protein. Further, N. meningitidis accumulated in the thyroid
gland, while thyroid hormone T4 levels decreased. Bacteria reached the mucosal surfaces of the upper respiratory tract, which
required expression of the meningococcal PilC1 adhesin. Surprisingly, PilC1 was dispensable for meningococcal growth in
blood and for crossing of the blood-brain barrier, indicating that the major role of PilC1 is to interact with mucosal surfaces.
This in vivo study reveals disease dynamics and organ targeting during meningococcal disease and presents a potent tool for
further investigations of meningococcal pathogenesis and vaccines in vivo. This might lead to development of new strategies
to improve the outcome of meningococcal disease in human patients.
Citation: Sjo ¨linder H, Jonsson A-B (2007) Imaging of Disease Dynamics during Meningococcal Sepsis. PLoS ONE 2(2): e241. doi:10.1371/
journal.pone.0000241
INTRODUCTION
Neisseria meningitidis is a human pathogen and a leading cause
world-wide of fatal sepsis and meningitis, usually in otherwise
healthy individuals [1]. The main reservoir of meningococcal
carriage is the human nasopharynx, where occasionally this
asymptomatic colonization is followed by invasive disease. The
disease progression is rapid and much remains unknown about the
disease process. Many meningococcal surface-associated virulence
factors have been characterized; among these are pili, PilC, Opa,
lipooligosaccharide (LOS) and the capsule. Meningococcal pili
mediate attachment to host cells, and each pilus is composed of
thousands of interactive PilE subunits, a pilus-associated adhesin
PilC, and possibly other not yet identified components. Opa
proteins are integral outer membrane proteins that mediate
invasion of human cells [2]. Many surface exposed virulence
factors of Neisseria undergo phase and antigenic variation, i.e.
alteration of gene expression by on-off switching of a given gene
product or by DNA rearrangement, which may augment bacterial
adaptability and virulence [3,4]. Opa expression undergoes phase
variation due to frequent changes in the number of pentameric
sequence repeats within the signal-peptide coding region, which
alter the open-reading frame. Studies of bacterial virulence factors
and host cell receptors have revealed complex and multifunctional
contact points and signal transduction patterns during interaction
between bacteria and target host cells [5–9]. Since N. meningitidis
normally causes disease only in humans, most studies of bacteria-
host cell interactions have been carried out in vitro, clearly limiting
the understanding of disease progression.
Several experimental model systems using mice, rats and rabbits
have been evaluated over the last few decades [10]. Iron-enhanced
i.p. mouse infection utilizing a spectrum of iron sources clearly
results in bacteremia [11], while i.n. infection in the presence of
iron dextran also leads to colonization of nasal tissue [12].
However, the main disadvantage of these models is the unknown
effect of iron on the host immune response and especially on the
innate defense mechanisms. I.n. infection in infant mouse models
may be used to study early events in the pathogenesis of
meningococcal infection, however these models are not ideal
since the bacteremia levels are low (maximum of 58%) while
meningitis seldom develops [13,14]. Infant rat models with i.p.
bacterial challenge results in high bacterial counts in blood and
CSF and high mortality rates [15,16], but still requires the
premature immune system of infant animals.
CD46 is a human cell surface complement regulator that
interacts with Neisseria and several other microbes [17]. CD46
transgenic mice infected intraperitoneally (i.p.) with N. meningitidis
are susceptible to meningococcal disease in contrast to nontrans-
genic mice that clear the infection and survive [18]. Importantly,
in the CD46 transgenic mouse model, infection leads to sepsis and
meningitis in adult mice without preinjection of enhancers, such as
iron compounds. Bacterial replication in the blood and passage
through the blood-brain barrier (BBB) occur in CD46 transgenic
mice, but not in nontransgenic mice. Furthermore, induction of
early immune responses after i.p. challenge of the transgenic mice
resemble manifestations of meningococcal disease in humans [19].
Therefore, CD46 transgenic mice represent a suitable model
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PLoS ONE | www.plosone.org 1 February 2007 | Issue 2 | e241system to study meningococcal disease and test vaccines in vivo in
adult mice.
In this study, we used in vivo bioluminescence imaging (BLI) to
monitor meningococcal sepsis in CD46 transgenic mice. Imaging
over time demonstrated waves of bacterial growth and clearance,
where bacterial signals diminished and then reappeared at novel
locations. Reappearance of bacteria was associated with turning
on of Opa expression. Furthermore, N. meningitidis accumulated in
the thyroid gland and nasal cavity. Interestingly, the meningococ-
cal adhesin PilC1 was dispensable for development of bacteremia
and for bacterial translocation to the cerebrospinal fluid (CSF), but
greatly enhanced bacterial translocation from blood to mucosal
surfaces of the upper respiratory tract.
RESULTS
In vivo imaging of bioluminescent N. meningitidis
In order to image the progression of meningococcal disease in vivo,
we constructed bioluminescently labeled N. meningitidis. The
luxCDABE genes, which are required for the production of
bioluminescent light, were expressed under the control of the
meningococcal porA promoter and inserted into a non-coding
chromosomal region of the meningococcal strain FAM20
(Figure 1A). As shown in Figure 1B, insertion of the porA promoter
significantly increased the bioluminescent signal. The biolumines-
cent strain FAM20
LU maintained expression of pili, PilC, LOS
and the capsule, and showed no changes in the pilE gene sequence
or growth rate as compared with the parent strain (data not
shown). To evaluate the virulence of FAM20
LU, we used a
previously reported mouse model [18] and challenged CD46
transgenic mice i.p. with 10
8 FAM20
LU. After 24 h, strong
bioluminescent signals were detected in the mouse body and in the
brain of CD46 transgenic mice, but no signals were seen in
nontransgenic mice (Figure 1C). As the original FAM20 strain,
FAM20
LU caused lethal disease within 2 days after infection.
Further, the intensity of the emitted signals was proportional to the
bacterial counts in blood and tissues (data not shown), allowing
both temporal and spatial analysis regarding meningococcal
disease progression. Construction of FAM20
LU resulted in both
Opa
ON and Opa
OFF clones, which showed no differences in
growth, in adhesion and invasion of host pharyngeal epithelial
cells, or in virulence using the CD46 transgenic mouse model
(Figure S1 and data not shown). In summary, the data from both
in vivo and in vitro experiments demonstrate that the novel
bioluminescent strains are stable and have equivalent virulence
as compared with the parental strain.
Three diverse disease patterns of meningococcal
disease in CD46 transgenic mice
Meningococcal disease begins when bacteria successfully enter the
bloodstream and survive host defenses. To study meningococcal
sepsis we set up an intravenous (i.v.) infection model in CD46
transgenic mice. We found that 1610
9 bacteria were an optimal
dose to induce severe meningococcal sepsis with a lethal outcome.
Infection with fewer bacteria, i.e. 5610
8/mouse, resulted in
clearance and 100% survival (data not shown). The optimal
infection dose was high, however, recent reports have shown that
patients with meningococcal disease may have bacterial loads of
up to 6610
8 bacteria/ml blood [20,21]. Infection with 10
9 CFU/
mouse corresponds to 5610
8 bacteria/ml in blood, which is within
the range of bacterial load found in humans. Thus, mice were
challenged with 10
9 bacteria/mouse and analyzed by biolumines-
cent imaging at different time points. As shown in Figure 2A,
nontransgenic mice infected with N. meningitidis cleared the
Figure 1. Generation and characterization of the bioluminescent N.
meningitidis strain FAM20
LU. (A) Chromosomal integration of a bio-
luminescence expression cassette into strain FAM20. The luxCDABE
operon of plasmid pLKMp is flanked by the Neisseria specific porA
promoter (P) and terminator (T) sequences of the gapdh gene. The
kanamycin resistance gene, kanR, enables selection on agar-plates. UHS
and DHS represent two sequences homologous to a non-coding region
between orf73 and orf74 of the FAM20 genome. (B) The porA promoter
enhances bioluminescent emission. Bioluminescence (in photon units)
emitted from N. meningitidis strain FAM20 transformed with pLKMp
(black line) or transformed with control vector without promoter (grey
line) is plotted against bacterial counts. (C) In vivo BLI of mice
challenged i.p. with 10
8 FAM20
LU. Mice were imaged at indicated time
points post-infection. In contrast to nontransgenic mice (upper panel),
strong signals in the body together with focal signals in the brain were
detected in CD46 transgenic mice (lower panel). Images show one
representative mouse from each group.
doi:10.1371/journal.pone.0000241.g001
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resulted in three different disease patterns. Many of the CD46
transgenic mice, i. e. 43% (20/46), demonstrated a ‘‘sepsis-like’’
pattern resulting in a lethal outcome within 2 days after infection.
In 35% (16/46) of the mice, a ‘‘meningitis-like’’ disease pattern
was observed with signals mainly located in the brain and spinal
region. Puncture of the cisterna magna of the mice in this group
revealed high bacterial numbers in CSF 24 h post-infection (data
not shown) and these mice died 2 or 3 days post challenge.
Interestingly, a ‘‘mild disease-like’’ pattern appeared in a smaller
number of mice (10/46), which displayed relatively low bacter-
emia levels of less than 10
6 CFU/ml (Figure 2B). Thus, infection
of CD46 transgenic mice leads to three different patterns of
disease.
Disease progression selects for Opa expression
We were interested to further analyze the mild meningococcal
disease. To study disease dynamics a more sensitive detection scale
was used to monitor bacterial load at 6 h, 1 day, 2 days, 3 days
and 4 days after i.v. infection (Figure 3A). Unexpectedly, the
signals disappeared after 2 days and the mice appeared to have
recovered. However, the signals reappeared day 3. Five out of ten
mice showed bacteria accumulating in the brain (Figure. 3A, top
panel), while the bacterial counts in the CSF were almost 1000
times higher than in the blood. The remaining mice displayed
strong signals in the whole body (Figure 3A, lower panel), with
high bacterial blood counts, indicating fulminant bacteremia.
Bacterial reappearance after the apparent recovery always led to
a lethal outcome. These data imply that meningococcal dissem-
ination in vivo is more complicated than we have previously
understood. Reappearance of bacteria at day 3 and 4 suggested
survival of a small population of bacteria. In an attempt to identify
possible phase and antigenic variation of meningococcal virulence
factors, bacteria were recovered from thyroid gland, thymus, lung,
liver, kidney, spleen, intestine, nasal wash, CSF, and blood, at day
1, 3 and 4 after infection with FAM20
LUOpa
OFF. All recovered
bacterial isolates retained expression of PilC, pili, LOS, and the
capsule (Figure 3B and data not shown). Further, sequence
variation of the pilE gene was not detected (data not shown).
Interestingly, in 67% (4/6) of the mice all isolates recovered at day
3 or later expressed Opa, whereas at earlier infection stages Opa-
expression was negative (Figure 3B, upper panels). Immunoblot
analysis demonstrated expression of OpaA and OpaB in all
isolates, while OpaD remained undetectable as in the initial
inoculum (Figure 3B and data not shown). The expression pattern
of Opa proteins was consistent after subculturing bacteria in vitro,
indicating that Opa expression was selected in mice. In order to
analyze the impact of Opa in disease development, CD46
transgenic mice were challenged i.v. with an Opa
ON isolate
recovered from blood. The bacterial blood counts were signifi-
cantly higher (5.6610
865610
8 CFU/ml) at 24 h post infection
compared with the initial inoculum (2610
761610
7 CFU/ml,
Figure 2. Meningococcal disease patterns in CD46 transgenic mice after i.v. infection. (A) BLI of nontransgenic mice and CD46 transgenic mice
challenged i.v. with 10
9 FAM20
LU at 6 and 24 h post-infection. Four mice are shown from each group, out of totally 46 mice. Signals at the tail region
originate from the injection site. (B) Frequency of disease patterns and bacteremia levels (mean 6 SD) in each group.
doi:10.1371/journal.pone.0000241.g002
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important role during disease progression.
Meningococci accumulate in the thyroid gland after
intravenous infection of CD46 transgenic mice
In addition to the bacterial signals in the mouse body and brain, in
vivo bioluminescence imaging (BLI) also revealed strong signals
that persisted over time in the thyroid gland and the nasal region
of CD46 transgenic mice (Figure 4A). Further analysis of the
thyroid gland demonstrated strong bioluminescence in a dissected
thyroid (Figure 4B), and high bacterial counts in homogenized
tissue (Figure 4C). Interestingly, the bacterial load was higher in
the thyroid than in the blood. Immunohistochemical examination
of thyroid tissue sections revealed that bacteria were primarily
located in cellular layers, and not in the lumen of thyroid follicles
(Figure 4D). Almost no bacteria were detected in thyroid glands
from nontransgenic mice. In order to investigate the thyroid
function during meningococcal disease, the blood level of the
thyroid hormone, thyroxine (T4), was measured. Unexpectedly,
Figure 3. Dynamic meningococcal disease progression selects for Opa expression. (A) Mice with mild-disease pattern were imaged over 4 days using
a detection scale of 200/2000 counts. Bioluminescent signals from the mice were undetectable at 2 days (2d) post-infection. From day 3 (3d), the
signals reappeared either in the brain (upper panel) or in the whole body (lower panel). Images are representative of each subgroup. Each panel
follows one mouse over time. Bacterial loads in blood and CSF at indicated time points post-challenge are shown. (B) N. meningitidis was isolated
from blood, CSF or nasal washes (N wash) at day 1, 3 and 4 after infection. Recovered isolates together with the initial inoculum, were analyzed for
expression of Opa proteins (30 kDa), PilC (110 kDa), and pili (PilE subunit 16 kDa) by immunoblots. LOS (6.5 kDa) was analyzed by Tricine SDS-PAGE.
doi:10.1371/journal.pone.0000241.g003
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nontransgenic mice (P,0.05). In response to infection, T4 levels
dropped in both CD46 transgenic mice and nontransgenic mice.
After 3 days of infection, T4 levels increased in nontransgenic
mice as the mice recovered, whereas T4 levels were undetectable
in CD46 transgenic mice after 2 days, which then had a lethal
outcome (Figure 4E).
N. meningitidis translocates from blood to the
respiratory mucosa
In vivo BLI also revealed a strong focal signal in the oral-
nasopharyngeal region of infected CD46 transgenic mice
(Figure 4A). This signal was detected over several days, sometimes
with increasing intensity. To analyze the presence of bacteria in
the nasopharynx, we collected nasal washes and measured the
bacterial counts. At 24 h post-infection, high numbers of bacteria
(7610
4 CFU/ml) were collected from nasal washes of CD46
transgenic mice, with over 95% of the recovered bacteria being
bioluminescent meningococci (Figure 5A). No meningococci were
found in nasal washes from infected nontransgenic mice or
uninfected mice kept in the same cage as the challenged mice
(Figure 5A and data not shown), indicating that meningococcal
colonization of the respiratory mucosa is not a consequence of
aerosol transfer of bacteria from other infected mice. Bacterial
transmigration to the respiratory mucosa was further verified by
immunohistochemical examination. Large numbers of meningo-
cocci were identified in the mucosa and submucosa of the nasal
cavity of CD46 transgenic mice challenged with FAM20
LU
(Figure 5B, upper panel). Furthermore, clusters of meningococci
were found in the nasal cavity and tracheal lumen, occasionally
associated with the mucosal surface (data not shown). These data
suggest the novel idea that N. meningitidis can translocate from
blood to the respiratory mucosal surface in CD46 transgenic mice.
Bacterial translocation from blood to the respiratory
mucosa is PilC1 dependent
The pilus-associated adhesin PilC1 plays a critical role in mediat-
ing attachment to host epithelial target cells [22,23]. In order to
study the role of PilC1 in meningococcal disease and bacterial
targeting to the respiratory mucosal surface, we generated a bio-
luminescently labeled PilC1 mutant. The resulting strain design-
ated FAM20DpilC1
LU displayed equivalent growth rates in vitro as
compared to FAM20
LU (data not shown). I.v. infection of mice
with the bioluminescent PilC1 mutant, resulted in strong
bacteremia, however, the bioluminescent signal in the nasal region
was weak (Figure 5A). Nasal washes confirmed fewer meningo-
cocci in mice infected with the PilC1 mutant (2610
2 CFU/ml)
than with the PilC1-expressing FAM20
LU (7610
4 CFU/ml)
(Figure 5A). Further, immunohistochemical examination failed
to detect the PilC mutant in the epithelial cell layer, although
minor amounts were detected in the submucosa (Figure 5B, lower
panel). Surprisingly, the PilC1 mutant induced bacteremia,
triggered IL-6, crossed the BBB, and caused lethal disease at
similar rates as the wild-type (Figure 6). Taken together, in vivo
investigations suggest that PilC1 is dispensable for bacteremia and
further bacterial passage through the blood-brain barrier, but
instead plays a crucial role in targeting N. meningitidis to the mucosa
of the upper respiratory tract.
DISCUSSION
Neisseria meningitidis is a strict human specific pathogen that causes
sepsis and meningitis. Meningococcal disease has a rapid onset
Figure 4. N. meningitidis targets the thyroid gland and the nasal area of
CD46 transgenic mice. (A) BLI of mice at 24 h after i.v. infection. Distinct
bioluminescent signals are visible in the thyroid area (T) and oral-nasal
region (N) of CD46 transgenic mice. (B) Ex vivo BLI imaging of a dissected
thyroid. (C) Bacterial loads in blood and thyroid at 24 h post-infection.
Significant difference between thyroid of CD46 transgenic mice and
nontransgenic mice is indicated (P,0.001). Bars indicate mean 6 SD.
(D) Immuno-histochemical examination of thyroid gland tissue sections
of mice infected for 24 h. Tissue sections were overlaid with antiserum
against N. meningitidis, followed by a FITC-conjugated anti-rabbit IgG.
Cell nuclei were counter-stained with DAPI (blue). Bacteria (shown in
green) are detected in the cellular layer of thyroid follicles of CD46
transgenic mice (inset). Scale bar: 20 mm. (E) Thyroxine (T4) levels in
mice. Sera were collected from CD46 transgenic (n=6) and nontrans-
genic mice (n=6) at indicated time points post-infection and T4 levels
were determined by enzyme immunoassay (EIA). Uninfected CD46
transgenic mice had significantly less T4 than nontransgenic mice
(P,0.05). Significant reductions of T4 compared with uninfected mice
are indicated with asterisks (*, P,0.05).
doi:10.1371/journal.pone.0000241.g004
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crucial for development of novel therapeutic strategies and
vaccines against meningococcal disease. In this study, we used
bioluminescent meningococci to image the disease progression in
CD46 transgenic mice and demonstrated novel aspects of the
dynamics of meningococcal disease. Imaging analysis of menin-
gococcal sepsis revealed for the first time, three disease patterns,
the two most common being sepsis and meningitis. The third
group of mice developed a mild disease pattern during the first
2 days of infection. In humans, N. meningitidis is most commonly
associated with rapid onset of meningitis and severe sepsis, but
Figure 5. Translocation of N. meningitidis to the respiratory mucosa is
dependent on PilC1. (A) Bioluminescent imaging of mice and nasal
washes spread on GC-plates 24 h post infection. CD46 transgenic mice
were infected i.v. with wild-type FAM20
LU or the PilC1-deficient mutant
FAM20DpilC1
LU. Nontransgenic mice were challenged with FAM20
LU.
Bacterial counts in the nasal washes (CFU/ml) are presented.
Significantly fewer PilC1 mutants were recovered compared with
wild-type bacteria (P,0.05). (B) Immunohistochemical detection of N.
meningitidis in nasal cavity sections of CD46 transgenic mice at 24 h
post-infection. Bacteria (dark brown) were detected with rabbit anti-N.
meningitidis antibody followed by HRP-conjugated goat anti-rabbit IgG
secondary antibody, and stained with DAB. Control sections have been
treated without the first antibody (w/o 1st Ab). Scale bar: 20 mm.
doi:10.1371/journal.pone.0000241.g005
Figure 6. In vivo virulence properties of FAM20DpilC1
LU. (A) Survival
rates of CD46 transgenic mice infected i.v. with PilC1-deficient
FAM20DpilC1
LU (grey line) or PilC-expressing FAM20
LU (black line).
Survival was monitored for 6 days. (B) Induction of the proinflammatory
cytokine, IL-6, in serum at 0 h, 6 h and 24 h post-infection was
measured by ELISA. Data are presented as mean 6 SD. (C) Bacterial
counts in CSF of CD46 transgenic mice at 48 h after infection with
FAM20DpilC1
LU (open bars) or FAM20
LU (black bars). Data are presented
as mean 6 SD.
doi:10.1371/journal.pone.0000241.g006
Meningococcal Sepsis
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i.v. challenge of transgenic mice with N. meningitidis resembles
human meningococcal disease features, supporting the system as
a useful tool for studying meningococcal pathogenesis in vivo.
In vivo imaging and immunohistochemistry showed accumula-
tion of bacteria in the thyroid gland of CD46 transgenic mice
(Figure 4). This finding encouraged us to analyze the function of
the thyroid by measuring the thyroid hormone T4 serum level. T4
was undetectable in CD46 transgenic mice after 2 days, whereas
in nontransgenic mice T4 levels returned to normal as bacteria
were cleared. These data indicate that an impaired thyroid
function is associated with more severe disease. Uncontrolled
release of proinflammatory cytokines occurs after meningococcal
challenge of CD46 transgenic mice [19]. Competition for limited
amounts of transcription factors involved in both cytokine
synthesis and thyroid hormone metabolism could explain the
resultant T4 reduction. In addition, it is also possible that
decreased T4 levels inhibit the bactericidal capacity of poly-
morphonuclear leukocytes (PMNLs) since thyroid hormones can
be an important iodine source for the myeloperoxidase-H2O2-
halide antimicrobial and cytotoxic system in human PMNLs [24].
Interestingly, in a septic rat model thyroid hormone supplemen-
tation showed a beneficial effect on both survival and the severity
of sepsis [25]. As shown in Figure 4E, CD46 transgenic mice have
constitutively lower levels of T4 than the nontransgenic control
mice. Further studies will address how CD46 influences the
thyroid function and whether low constitutive T4 levels increases
the susceptibility to meningococcal disease. It has been reported
that T4 is reduced at the beginning of bacterial and viral
meningitis in human infant patients [26]. However, there is no
available data about the frequency of ongoing thyroid disorder in
patients with meningococcal disease.
N. meningitidis can adapt to the host environment and escape the
immune defenses via phase and antigenic variation of surface
components. Earlier studies of experimental gonococcal urethritis
in human volunteers have shown that Opa proteins are not
required for the initial colonization of N. gonorrhoeae to host
epithelium, instead Opa protein expression is selected during the
course of infection [27]. In this study, N. meningitidis that
reappeared in mice at later stages of infection invariably expressed
Opa, independent of the isolation sites. The inoculum did not
express detectable Opa protein. However, bacteria that translo-
cated to CSF and respiratory mucosa at day 1 post-infection also
lacked Opa, indicating that these steps are independent of Opa
expression. Our data suggest that turning on Opa expression
probably enhances late stage meningococcal adaptation and
survival. Further, reappearance of bacteria shows that meningo-
cocci are capable of rapid growth in CD46 transgenic mice.
An interesting and novel finding in this study is the translocation
of N. meningitidis to the respiratory mucosa of CD46 transgenic
mice after i.v. infection. The PilC1 mutant did not reach the upper
respiratory mucosa, indicating that bacterial interaction with
respiratory epithelium is PilC1 dependent and probably not a result
of vascular leakage in the nasal cavity. Thus, in vivo data in this
study support previous in vitro findings that PilC1 mediates a direct
interaction with epithelial cells [22]. Both PilC1-expressing N.
meningitidis and the PilC1 mutant induced bacteremia, meningitis
and uncontrolled release of proinflammatory cytokines. Therefore,
PilC1 is most likely dispensable for meningococcal interactions
with host immune defenses in blood and passage across the BBB.
Since both the PilC1 mutant and the wild-type strain induced
similar proinflammatory responses (Figure 6B), it is still possible
that entry of the PilC1 mutant into the CSF may be a result from
sepsis-induced cell damage of the BBB.
N. meningitidis reached the CSF and the respiratory mucosa in
CD46 transgenic mice, but not in nontransgenic mice, suggesting
that CD46 is a critical component of disease, either by interacting
with bacteria at the site of translocation or by protecting bacteria
at earlier stages allowing bacterial survival. Since the PilC1 mutant
were not found at the respiratory mucosa, but crossed the BBB, it
is likely that the mechanisms by which N. meningitidis interacts with
these two cellular barriers are different. In humans, CD46 is
expressed as four major isoforms, BC1, BC2, C1 and C2,
depending on alternative splicing of an extracellular serine/
threonine/proline rich domain and the choice between one of two
cytoplasmic tails, Cyt-1 and Cyt-2 [28]. It has been reported that
CD46 transgenic mice express distinct CD46 isoforms in throat
epithelium and the BBB [18]. Hence, different mechanisms for
bacterial adhesion and invasion might be required. Nevertheless,
our data cannot exclude that an additional unknown factor may
interact with PilC1 at the respiratory epithelium [29].
In conclusion, this study demonstrates that bioluminescent N.
meningitidis strains together with the CD46 transgenic mouse model
provide a potent tool for in vivo investigations of meningococcal
disease. Disease dynamics and thyroid targeting during meningo-
coccal sepsis revealed in this study might lead to new strategies to
improve the clinical outcome in human patients.
MATERIALS AND METHODS
Bacterial strains and growth conditions
Escherichia coli DH5a was used for cloning. N. meningitidis FAM20
belongs to serogroup C, MLST sequence type 11. The FAM20
PilC1 mutant strain, FAM20DpilC1, has been described previously
[30]. Neisseria strains were grown at 37uC in a 5% CO2 atmo-
sphere on GC agar (Difco) supplemented with Kelloggs, or in GC-
liquid medium as described [19]. For selection of bioluminescent
N. meningitidis transformants, kanamycin was added at concentra-
tions of 50 mg/ml.
Generation of bioluminescent N. meningitidis
strains
Plasmid pXen-13 containing the luxCDABE operon was modified
to pLKMp by insertion of a Neisseria specific promoter sequence,
terminator sequence, kanamycin resistance gene, DNA uptake
sequence and two DNA fragments homologous to a non-coding
region of the FAM20 genome (Figure 1A and Table 1). The
Table 1. Primers used for generation of the pLKMp plasmid
......................................................................
Product Sequence of primer pairs*
Restriction
site
KanR 59-gatgaatgtcgactactgggccgtctgaacaagggaaaacg-39 Sal I
59-ctggaacaacacggatccctatcgcggtctattcttttg-39 BamHI
Promoter 59-aatagtacgg atccgattca cttggtgctt cagcacc-39 BamHI
59-cgagggcggtaagtttttttcgcagatctgcttcc-39 BglII
Terminator 59-ttcgcaggccggccgtaagg cttgaacaaa cctgtgg-39 Eae I
59-tttgttcgccagcggccgcaatatcaagttatagcgg-39 Not I
UHS 59-aacaatagagcagtacttcccggcaggtcaaattg-39 Sca I
59-gctaacagaaaactcgagtccactattgttagggg-39 Xho I
DHS 59-cttggttacagcggccgcatgattgcaaataatgag-39 Not I
59-cgtaaatggtttcagagctcataatttttctctttc-39 Sac I
*Restriction enzyme cleavage sites are marked in bold. The DNA uptake
sequence is underlined.
doi:10.1371/journal.pone.0000241.t001
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(Invitrogen) and cloned into a SalI/BamHI site of the plasmid
pXen-13. A 10-bp DNA uptake sequence required for efficient
DNA transformation of Neisseria [31] was introduced into the 59
end of the kanamycin cassette. Porin proteins are the most
prevalent components of the Neisseria outer membrane and are
essential for bacterial survival [32]. In order to increase the
expression level of the luxCDABE operon in N. meningitidis, a 390
bp promoter sequence of the porA gene from strain FAM20 was
PCR amplified and cloned into a BamHI site upstream of the
luxCDABE operon. Furthermore, a 200 bp transcription termi-
nator region of the gapdh gene from strain FAM20 was amplified
and cloned into a NotI site downstream of the luxCDABE operon.
The plasmid contained the porA promoter upstream of the
luxCDABE expression cassette was named pLKp. In addition,
a plasmid without promoter was used as a control.
For chromosomal integration of plasmid pLKp by homologous
recombination, two DNA fragments (UHS and DHS) from
a region between orf73 and orf74 of the FAM20 genome, which
does not contain inverted repeat sequences, were amplified and
cloned into plasmid pLKp upstream of the kanamycin gene and
downstream of the terminator, respectively. The luxCDABE
expression cassette was integrated into the N. meningitidis strain
FAM20 and the corresponding PilC1-deficient mutant. The
transformation method has been described previously [33]. Single
copy plasmid integration into the bacterial genome was confirmed
by Southern blot analysis (data not shown).
Mouse strains
The hCD46Ge transgenic mouse line was created using B6C3F1
hybrids. It harbors the complete human CD46 gene and expresses
CD46 in a human-like pattern [34]. The F1 generation of
C57BL/6 and C3H/Hen mice, i. e. B6C3F1, was therefore used
as nontransgenic control in this work. All mice were bred at the
animal facility of the Microbiology and Tumor Biology Center,
Karolinska Institutet, and at the animal facility of the Biomedical
Center, Uppsala University. Experiments were performed with
6–10 week old, age- and gender-matched mice and were repeated
for five times with similar results. Animal care and experiments
were in accordance with institutional guidelines and have been
approved by national ethical committees.
Animal procedures
N. meningitidis was suspended in GC medium to appropriate
bacterial concentrations. Mice were infected i.p. or i.v. in the tail
vein. CSF was withdrawn from cisterna magna and the CSF
samples were checked for the absence of red blood cells before
spreading on the GC agar. Nasal washes were collected as
described previously [35]. Organs were excised from sacrificed
mice, weighed and homogenized in PBS. Blood samples were
obtained from the tail vein. Bacterial counts were determined by
plating serial dilutions of samples on GC plates.
Bioluminescence imaging
For in vivo imaging, mice were anaesthetized and imaged for
a maximum of 2 min using an IVIS imaging system (Xenogen
Corporation/Caliper Life Sciences) according to the manufacturer’s
instructions. Total bioluminescence emission from whole mouse or
defined areas within the images of each mouse was quantified (in
photon units) using the Living Image software package (Xenogen
Corporation/Caliper Life Sciences). The dark fur of the mice was
shaved away in order to increase the sensitivity of signal detection.
For in vitro studies, images of bacterial plates or dissected organs were
acquired with a 1 min exposure. The bioluminescence signals
remained stable over time since bacteria recovered from mice
produced similar signals as compared with the inoculum. Further,
the bacterial blood counts in septic mice were proportional to the
intensity of the bioluminescent signals over time.
Immunoblotting, LOS preparation, capsule
measurement, and DNA sequencing
Expression of meningococcal opacity (Opa) proteins, pilus-
associated proteins (PilC), and type IV pili proteins was detected
by immunoblot analysis. Sample preparation and immunoblot
conditions have been described previously [36]. Opa-specific
mouse monoclonal antibodies (H22.1, H21.1, 4B12/C11, and
7-24-D9) were kind gifts from Dr. M. Achtman (Max Planck
Institut fuer Molekular Genetik, Berlin, Germany) and Dr. J.
Cannon (University of North Carolina, United States). 4B12/C11
recognizes all Opa proteins, H21.1 recognizes OpaB, H22.1
recognizes OpaA and OpaD, and 7-24-D9 recognizes OpaD [37].
PilC antiserum was generated in rabbits against the full-length
PilC1 of N. meningitidis FAM20. Pili antiserum was produced in
rabbits against highly purified pili of N. meningitidis FAM20 [30].
LOS was isolated, separated on tricine SDS-PAGE and visualized
by silver staining [33]. Capsule expression was determined by co-
agglutination analysis. The pilE gene of 5 independent isolates
recovered from blood, CSF and nasal washes at different time
points after infection was amplified by PCR and sequenced using
primers 59-GATGCCGCAAATTTCCAATC-39 and 59-TCAC-
GACCGGGTCAAACC-39.
Histology and immunohistochemistry
Mice were anesthetized and transcardially perfused with PBS.
Organs were removed, fixed in 4% paraformaldehyde and
embedded in paraffin. For detection of meningococci the tissue
sections were incubated with rabbit antibody against N. meningitidis
(diluted 1:50; USBiological) for 60 min, horseradish peroxidase
(HRP)-conjugated goat anti-rabbit IgG (diluted 1:50; BioRad) for
60 min, and stained using ImmunoPure metal Enhanced DAB
substrate (Pierce). For fluorescent immunohistochemistry, FITC-
conjugated goat anti-rabbit IgG (diluted 1:100; Santa Cruz) was
applied as a secondary antibody. Sections were visualized with Carl
Zeiss Axio Vision 2.05 image processing and analysis system (Zeiss).
Determination of IL-6 and Thyroxine (T4) levels in
serum
Concentrations of murine IL-6 and T4 in mouse serum was
determined in duplicate using ELISA (Diaclone) and a OpticoatH
Thyroxine (T4) enzyme immunoassay (EIA) kit (Biotecx Labs)
according to manufacturer’s recommendations.
Statistical analysis
Differences in survival rates were assessed using a Fisher’s exact
test. Bacterial counts in blood and organs were analyzed by non-
parametric Mann-Whitney test. A two-sided student’s t-test was
used to assess significance in the cytokine and thyroxine assays.
Values of P,0.05 were considered significant.
SUPPORTING INFORMATION
Figure S1 Adhesion to and invasion into FaDu cells by the
parent FAM20 and the bioluminescent FAM20
LU strains.
Found at: doi:10.1371/journal.pone.0000241.s001 (0.24 MB
DOC)
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